https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-16 / Inflammation 2024 Mar;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-16 / Inflammation 2024 Mar;2024-03-16 00:00:002024-03-16 00:00:00An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-09-07 / Hepatobiliary Pancreat Dis Int 2022 Oct;21(5):440-449
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-09-07 / Hepatobiliary Pancreat Dis Int 2022 Oct;21(5):440-4492022-09-07 00:00:002022-09-07 00:00:00Current and emerging immunotherapeutic approaches for biliary tract cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-11-17 / Cancers (Basel) 2020 Nov;12(11)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-11-17 / Cancers (Basel) 2020 Nov;12(11)2020-11-17 00:00:002024-08-26 09:18:25A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-01-24 / Hum Vaccin Immunother 2020 Oct;16(10):2318-2327
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-01-24 / Hum Vaccin Immunother 2020 Oct;16(10):2318-23272020-01-24 00:00:002020-01-24 00:00:00Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-3955
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-39552019-08-07 00:00:002019-08-07 00:00:00Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-27 / Clin Colorectal Cancer 2019 Jun;18(2):81-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-27 / Clin Colorectal Cancer 2019 Jun;18(2):81-902019-02-27 00:00:002019-02-27 00:00:00Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-03-29 / Cancer Immunol Immunother 2018 Dec;67(12):1897-1910
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-03-29 / Cancer Immunol Immunother 2018 Dec;67(12):1897-19102018-03-29 00:00:002024-11-03 11:46:45Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-21 / Hum Vaccin Immunother 2018 Jun;14(6):1423-1431
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-21 / Hum Vaccin Immunother 2018 Jun;14(6):1423-14312018-02-21 00:00:002018-02-21 00:00:00Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-31 / Curr Probl Cancer 2018;42(1):49-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-31 / Curr Probl Cancer 2018;42(1):49-582017-10-31 00:00:002017-10-31 00:00:00Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-26 / Integr Cancer Ther 2018 06;17(2):558-561
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-26 / Integr Cancer Ther 2018 06;17(2):558-5612017-07-26 00:00:002019-02-15 08:37:24Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report
